Kirk A. Sigmon and Scott M. Kelly discuss ways to make the process of getting a high-quality, blockchain-directed patent faster and easier in World Intellectual Property Review. Click here to read,
Pei Wu discusses how a well-devised intellectual property portfolio can go a long way to ensure a startup biotech company’s success in the marketplacein IPWatchdog. Click here to read, “Cost-Effective
Recalibrating the Alice/Mayo Test By Sarah A. Kagan Repeated challenges to invalidity holdings of diagnostic method claims under the Alice/Mayo framework at the U.S. Court of Appeals for the
Banner & Witcoff, Ltd., a national intellectual property law firm that procures, enforces and litigates intellectual property rights throughout the world, welcomes Blair A. Silver as an Of Counsel attorney
The Licensing Executives Society (USA & Canada) recently appointed Gary D. Fedorochko as President-Elect and Chair-Elect for the 2018-2019 year. He previously served as Senior Vice President, Meetings, Education &
Banner & Witcoff is recognized as one of the best performing and most active law firms in inter partes review in Patexia’s 2018 IPR Intelligence Report. This third-party study –
New Claim Construction Standard at the PTAB as of November 13, 2018 By Bradley J. Van Pelt The U.S. Patent and Trademark Office has now issued a final rule
Is a New Crystal Polymorph Useful and Non-Obvious Over a Prior Art Form of the Same Chemical Formula? By Sarah A. Kagan Four Abbreviated New Drug Application (ANDA) litigants
Aseet Patel discusses the potential for more clarity for United States patents involving software innovations, and how that could lead to an improvement in depressed patent valuations, increase in patent licensing activity and raised
Sarah A. Kagan discusses the potential impact of the Federal Circuit’s decision invalidating patents on Acorda Therapeutics Inc.’s multiple sclerosis drug Ampyra in Law360. Ms. Kagan authored an amicus brief that BIO filed
